In mouse models, tumor-derived CCL21 recruits NKp46- ILC3s, which trigger stromal CXCL13 production, leading to RANKL expression and enhanced cancer cell motility and dissemination (Figure 3F) (187). This evidence concerns the gene NCR1 and neoplasm.